Cargando…

Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission

Detalles Bibliográficos
Autores principales:	Goh, J, Mason, J, Chan, J, Moradi, M, Berek, J, Beningno, B, Mileshkin, L, Recio, F, Tchabo, N, Rossi, E, Eisenberg, P, Rose, P, Mitchell, P, Young, J, Matos, M, Secord, A, Davy, M, Gargosky, S, Gray, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991068/ http://dx.doi.org/10.1186/2051-1426-1-S1-P213

Ejemplares similares

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial
por: Gray, H. J., et al.
Publicado: (2016)

Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1
por: Gargosky, Sharron, et al.
Publicado: (2014)

A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer
por: Mitchell, Paul LR, et al.
Publicado: (2014)

Divergent Autologous T Cell Responses to Leukaemic Dendritic Cells during Remission in Acute Promyelocytic Leukaemia
por: Westers, Theresia M., et al.
Publicado: (2005)

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome
por: Dorresteijn, Eiske M., et al.
Publicado: (2008)

Immunotherapy using BCG during remission induction and as the sole form of maintenance in acute myeloid leukaemia.
por: Summerfield, G. P., et al.
Publicado: (1979)

Failure to detect autologous antibodies in the remission sera of patients with AML: complications introduced by the presence of rheumatoid factor.
por: James, S. E., et al.
Publicado: (1980)

Brentuximab vedotin maintenance after autologous stem cell transplantation for refractory gray zone lymphoma with long-term remission
por: Terao, Toshiki, et al.
Publicado: (2021)

The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia.
por: Lennard, L., et al.
Publicado: (1986)

Remission in Crohn’s disease is accompanied by alterations in the gut microbiota and mucins production
por: Magro, Daniéla Oliveira, et al.
Publicado: (2019)

Remission of severe myasthenia gravis after autologous stem cell transplantation
por: Schlatter, Monica I., et al.
Publicado: (2023)

Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus
por: Bonilla-Abadía, Fabio, et al.
Publicado: (2014)

CLIPPERS: Induction and maintenance of remission using hydroxychloroquine
por: Tan, Boon Loong, et al.
Publicado: (2015)

Vedolizumab for induction and maintenance of remission in Crohn's disease
por: Hui, Samuel, et al.
Publicado: (2023)

Expression of Mucins in Different Entities of Salivary Gland Cancer: Highest Expression of Mucin-1 in Salivary Duct Carcinoma: Mucin-1 – highest expression in Salivary Duct Carcinoma
por: Wolber, P., et al.
Publicado: (2022)

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
por: Kamm, M A, et al.
Publicado: (2008)

MARCKS-dependent mucin clearance and lipid metabolism in ependymal cells are required for maintenance of forebrain homeostasis during aging
por: Muthusamy, Nagendran, et al.
Publicado: (2015)

An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease
por: Haskey, Natasha, et al.
Publicado: (2017)

Durable remission in a patient with ERBB2-amplified recurrent mucinous ovarian carcinoma treated with Trastuzumab-Carboplatin-Paclitaxel
por: Neil, Alexander J., et al.
Publicado: (2023)

HIGH PROBABILITY OF LONG-TERM SURVIVAL IN 2-YEAR SURVIVORS OF AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA IN FIRST OR SECOND COMPLETE REMISSION
por: Majhail, Navneet S., et al.
Publicado: (2010)

Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
por: Jackson, G. H., et al.
Publicado: (1994)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
por: Chen, An-Yu, et al.
Publicado: (2019)

Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia
por: Buyse, Marc, et al.
Publicado: (2011)

Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease
por: Papakrivopoulou, Eugenia, et al.
Publicado: (2016)

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2019)

Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantation
por: Ruiz, Milton Artur, et al.
Publicado: (2015)

Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes
por: Kontani, K, et al.
Publicado: (2001)

The Steroids In the Maintenance of remission of Proliferative Lupus nephritis (SIMPL) pilot trial
por: Galbraith, Lauren, et al.
Publicado: (2014)

Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containment
por: Actis, Giovanni C, et al.
Publicado: (2017)

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
por: Naganuma, Makoto, et al.
Publicado: (2021)

Poor Adherence With Medication Refill and Medical Supplies Maintenance as Risk Factors for Inpatient Asthma Admission in Children
por: Poowuttikul, Pavadee, et al.
Publicado: (2017)

Cell genesis and dendritic plasticity: a neuroplastic pas de deux in the onset and remission from depression
por: Mateus-Pinheiro, A, et al.
Publicado: (2013)

A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy
por: Huang, Zhenghua, et al.
Publicado: (2023)

P1376: LENALIDOMIDE–BASED MAINTENANCE AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT FOR PATIENTS WITH HIGH RISK MULTIPLE MYELOMA
por: Pasvolsky, O., et al.
Publicado: (2022)

Effectiveness of Remission Induction Strategies for Early Rheumatoid Arthritis: a Systematic Literature Review
por: Verhoeven, M. M. A., et al.
Publicado: (2019)

Maintenance of Remission with Partial Enteral Nutrition Therapy in Pediatric Crohn's Disease: A Retrospective Study
por: Schulman, Jacqueline M., et al.
Publicado: (2017)

Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Patients with Crohn’s Disease: a Pilot Randomized Placebo-Controlled Trial
por: Mikocka-Walus, Antonina, et al.
Publicado: (2017)

Autophagy of mucin granules contributes to resolution of airway mucous metaplasia
por: Sweeter, J. M., et al.
Publicado: (2021)

Ocular mucins: Purification, metabolism and functions
por: Corfield, Anthony P., et al.
Publicado: (1997)

Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
por: Wu, Kai-Chun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uoejs84p8rpanq9kd54k288hmc